Introduction
In the pharmaceutical industry, maintaining product quality and patient safety is the highest priority. Every material used in manufacturing must meet strict quality standards. However, sometimes raw materials, packaging materials, or finished goods fail to meet required specifications during quality control testing or inspection.
Such materials are classified as rejected materials and must be handled carefully to prevent accidental use in production.
Improper handling of rejected materials in pharma can lead to serious GMP violations, product contamination, regulatory actions, or product recalls. Therefore, pharmaceutical warehouses must follow a strict SOP-based system for identification, segregation, storage, documentation, and disposal of rejected materials.
This article explains the complete GMP procedure for handling rejected materials in pharmaceutical manufacturing facilities.
Quick Answer
Rejected material handling in pharmaceutical warehouses refers to the controlled process of identifying, labeling, segregating, storing, documenting, and disposing of materials that fail to meet quality specifications during inspection or testing, ensuring they are never used in manufacturing.
Materials that fail QC testing after the quarantine stage must be handled carefully according to GMP procedures. You can learn more about the quarantine process in our guide on material quarantine in a pharma warehouse.
What are Rejected Materials in Pharma?
Rejected materials are any raw materials (RM), packaging materials (PM), or finished goods (FG) that do not comply with quality specifications, GMP requirements, or regulatory standards.
These materials are rejected by the Quality Control (QC) or Quality Assurance (QA) department after testing, inspection, or investigation.
Common Examples of Rejected Materials
• Raw materials failing laboratory testing
• Damaged packaging materials
• Incorrect labeling of materials
• Contaminated materials
• Expired materials
• Finished goods failing quality testing
Types of Rejected Materials in Pharma
1. Rejected Raw Materials (RM)
These are raw materials that fail QC laboratory testing, such as:
- Identity test failure
- Assay failure
- Microbial contamination
- Impurities exceeding limits
Example:
A batch of lactose monohydrate fails assay testing and is rejected by QC.
2. Rejected Packaging Materials (PM)
Packaging materials may be rejected due to:
- Printing errors
- Incorrect batch coding
- Physical damage
- Wrong specifications
Example:
Blister foils printed with an incorrect batch number are rejected.
3. Rejected Finished Goods (FG)
Finished products may be rejected if they fail:
- Dissolution test
- Weight variation
- Stability testing
- Appearance inspection
Example:
Tablets showing black spots during visual inspection.
GMP Requirements for Handling Rejected Materials
According to World Health Organization GMP and U.S. Food and Drug Administration regulations, rejected materials must be:
• Clearly identified
• Physically segregated
• Stored in restricted areas
• Properly documented
• Disposed of or returned under QA approval
This prevents mix-ups, accidental use, and quality risks.
Step-by-Step Procedure for Handling of Rejected Materials in Pharma
Step 1: Identification of Rejected Materials
Rejected materials are identified after:
- QC testing failure
- Warehouse inspection
- Production deviation
- Stability failure
QC issues a rejection report or test report confirming the failure.
Step 2: Labeling of Rejected Materials
The warehouse team must immediately attach a Rejected Label containing:
• Material name
• Batch number
• Quantity
• Rejection status
• Date
• QC/QA signature
This ensures clear visual identification.
Rejected materials must be clearly identified using pharmaceutical status labels such as Approved, Quarantine, or Rejected to avoid mix-ups during warehouse operations.
Step 3: Segregation of Rejected Materials
Rejected materials must be physically separated from approved materials.
Typical segregation methods include:
• Dedicated rejected material area
• Red color floor marking
• Separate racks or cages
• Restricted access area
This prevents accidental usage in production.
Step 4: Transfer to Rejected Material Storage Area
After labeling, materials are transferred to a designated rejected material storage area in the warehouse.
The area should be:
• Locked or restricted
• Clearly labeled
• Separate from approved material storage
• Under QA control
Step 5: Documentation and Record Entry
Warehouse personnel must update documentation such as:
• Rejected Material Register
• ERP / inventory system entry
• QC rejection report
• Material movement record
Accurate documentation ensures traceability and audit compliance.
Step 6: QA Review and Decision
The QA department reviews the rejected material and decides the final action:
• Destruction
• Return to supplier
• Reprocessing (if allowed)
• Investigation
The decision is recorded in the rejection report.
Step 7: Disposal or Return of Rejected Materials
After QA approval, rejected materials are:
Returned to Supplier
Used when:
- Supplier quality issue
- Damaged material received
- Wrong specification supplied
Destroyed
Used when:
- Contamination risk
- Stability failure
- Non-recoverable materials
Destruction must follow environmental and regulatory guidelines.
Equipment and Documents Required
Equipment
• Pallets
• Segregation racks
• Locked cages
• Rejected material labels
Documents
• Rejection report
• Material rejection register
• SOP for rejected materials
• Material return note
• Destruction record
Advantages of Proper Rejected Material Handling
• Prevents accidental use of poor-quality materials
• Maintains GMP compliance
• Protects product quality
• Improves audit readiness
• Ensures regulatory compliance
Risks of Poor Rejected Material Handling
• Product contamination
• Manufacturing deviations
• Regulatory warning letters
• Product recalls
• Patient safety risks
Improper handling of rejected materials can lead to serious quality issues. Conducting a proper risk assessment in pharmaceutical industry helps identify and control potential risks in warehouse operations.
Real Pharmaceutical Industry Example
During a warehouse inspection at a tablet manufacturing plant, a batch of microcrystalline cellulose failed microbial testing.
The warehouse team immediately:
- Labeled the material as Rejected
- Moved it to the Rejected Material Area
- Updated the rejection register
- QA reviewed the case and returned the material to the supplier
This prevented contamination risk in tablet production.
Conclusion
Handling of rejected materials in the pharmaceutical industry is a critical part of Good Manufacturing Practices (GMP) and warehouse quality control. Any material that fails to meet quality specifications must be immediately identified, clearly labeled, and stored in a designated rejected material area to prevent accidental use in manufacturing.
A well-defined procedure ensures that rejected raw materials, packaging materials, or finished goods are properly segregated, documented, and controlled under QA supervision. This process maintains product quality, regulatory compliance, and patient safety.
By following a structured system that includes identification, labeling, segregation, documentation, and final disposal or return to the supplier, pharmaceutical companies can prevent mix-ups, avoid regulatory risks, and maintain high GMP standards.
In simple terms, proper handling of rejected materials protects the integrity of pharmaceutical products and ensures that only approved, quality-compliant materials enter the manufacturing process.
Frequently Asked Questions (FAQ)
What is the procedure for handling rejected materials in pharmaceutical warehouses?
The procedure for handling rejected materials in pharmaceutical warehouses involves identifying the material, attaching a rejected label, segregating it from approved materials, storing it in a designated rejected material area, documenting the rejection, and taking final action, such as return to the supplier or destruction under QA approval.
Who is responsible for handling of rejected materials in the pharma?
Handling of rejected materials is mainly performed by the warehouse team, but the Quality Assurance (QA) department controls the decision for rejection, investigation, and final disposition, such as destruction or supplier return.
How are rejected raw materials stored in pharmaceutical warehouses?
Rejected raw materials must be stored in a separate, clearly marked rejected material area with restricted access. These materials are kept away from approved materials to prevent mix-ups or accidental use during manufacturing.
What label is used for rejected materials in pharmaceuticals?
A Rejected Status Label, usually red in color, is used for rejected materials. The label contains information such as material name, batch number, quantity, rejection status, date, and QC or QA authorization.
Can rejected materials be reprocessed in pharmaceutical manufacturing?
In some cases, rejected materials may be reprocessed or re-evaluated if approved by the QA department after proper investigation. However, this depends on regulatory guidelines, product safety, and GMP compliance.
Why is segregation of rejected materials important in pharma warehouses?
Segregation is important because it prevents mix-ups, cross-contamination, and accidental use of non-conforming materials in pharmaceutical manufacturing, which could affect product quality and patient safety.
What happens to rejected finished goods in pharmaceutical companies?
Rejected finished goods are usually destroyed under QA supervision to ensure they do not enter the market. In some cases, they may be investigated or reprocessed depending on the nature of the defect.
What documentation is required for rejected material handling in pharma?
Important documents include:
Rejection report
Rejected material register
Material movement record
Material return note
Destruction record
These documents ensure full traceability and audit compliance.
What are the common reasons for material rejection in pharmaceutical manufacturing?
Common reasons include:
QC testing failure
Contamination
Incorrect specifications
Physical damage
Expired materials
Packaging defects
These issues lead to materials being classified as rejected materials.
What GMP guidelines apply to rejected materials in pharmaceuticals?
GMP guidelines from organizations such as World Health Organization and U.S. Food and Drug Administration require rejected materials to be clearly identified, segregated, documented, and controlled to prevent accidental use in pharmaceutical manufacturing.